Merit Medical Systems Total Assets 2010-2023 | MMSI

Merit Medical Systems total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
Merit Medical Systems Annual Total Assets
(Millions of US $)
2022 $1,664
2021 $1,648
2020 $1,664
2019 $1,757
2018 $1,620
2017 $1,112
2016 $943
2015 $779
2014 $747
2013 $728
2012 $705
2011 $447
2010 $369
2009 $272
Merit Medical Systems Quarterly Total Assets
(Millions of US $)
2023-09-30 $1,809
2023-06-30 $1,838
2023-03-31 $1,684
2022-12-31 $1,664
2022-09-30 $1,633
2022-06-30 $1,632
2022-03-31 $1,630
2021-12-31 $1,648
2021-09-30 $1,643
2021-06-30 $1,642
2021-03-31 $1,652
2020-12-31 $1,664
2020-09-30 $1,671
2020-06-30 $1,716
2020-03-31 $1,749
2019-12-31 $1,757
2019-09-30 $1,762
2019-06-30 $1,736
2019-03-31 $1,690
2018-12-31 $1,620
2018-09-30 $1,310
2018-06-30 $1,291
2018-03-31 $1,239
2017-12-31 $1,112
2017-09-30 $1,087
2017-06-30 $1,052
2017-03-31 $1,015
2016-12-31 $943
2016-09-30 $929
2016-06-30 $815
2016-03-31 $803
2015-12-31 $779
2015-09-30 $768
2015-06-30 $755
2015-03-31 $740
2014-12-31 $747
2014-09-30 $747
2014-06-30 $744
2014-03-31 $742
2013-12-31 $728
2013-09-30 $718
2013-06-30 $728
2013-03-31 $712
2012-12-31 $705
2012-09-30 $519
2012-06-30 $500
2012-03-31 $489
2011-12-31 $447
2011-09-30 $419
2011-06-30 $458
2011-03-31 $380
2010-12-31 $369
2010-09-30 $364
2010-06-30 $280
2010-03-31 $277
2009-12-31 $272
2009-09-30 $265
2009-06-30 $257
2009-03-31 $241
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.617B $1.151B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.527B 20.19
McKesson (MCK) United States $66.590B 17.82
West Pharmaceutical Services (WST) United States $25.910B 43.34
Cardinal Health (CAH) United States $25.629B 15.40
Align Technology (ALGN) United States $24.013B 47.58
Cooper (COO) United States $19.020B 29.91
Labcorp (LH) United States $18.310B 15.49
Henry Schein (HSIC) United States $9.829B 14.98
DENTSPLY SIRONA (XRAY) United States $7.150B 18.24
Patterson (PDCO) United States $2.632B 12.03
CONMED (CNMD) United States $2.500B 23.56
STAAR Surgical (STAA) United States $1.503B 68.42
Atrion (ATRI) United States $0.627B 29.47
Lifevantage (LFVN) United States $0.089B 14.42
Pro-Dex (PDEX) United States $0.061B 23.32
Biolase (BIOL) United States $0.001B 0.00